• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 1 fuera de 4 páginas
Examen

Nrsg 330 Endocrine Case Study Answer

Document preview thumbnail
Vista previa 1 fuera de 4 páginas

NRSG 330 ENDOCRINE CASE STUDY NRSG 330 ENDOCRINE CASE STUDY NRSG 330 ENDOCRINE CASE STUDY You work in the diabetes mellitus (DM) center at a large teaching hospital. The first patient you meet is K.W., a 25-year-old Hispanic woman, who was just released from the hospital 2 days ago after being diagnosed with type I DM. Nine days ago, K.W. went to see the physician after a 1-month history of frequent urination, thirst, severe fatigue, blurred vision, and some burning and tingling in her feet. She attributed those symptoms to working long hours at the computer. Her random glucose level was 410 mg/dL. The next day her laboratory values were as follows: fasting glucose 335 mg/dL, hemoglobin A1C (HbA1c) 8.8%, cholesterol 310 mg/dL, triglycerides 300 mg/dL, high-density lipoprotein (HDL) 25 mg/dL, low-density lipoprotein (LDL) 160 mg/dL, ratio 12.4, and creatinine 0.9 mg/dL. Her body mass index is 37.6. Her blood pressure (BP) is 160/96 mm Hg. She was admitted to the hospital for control of her glucose levels and the initiation of insulin therapy with carbohydrate (CHO) counting. After discharge, K.W. has been referred to you for comprehensive education. You are to cover four basic areas: pharmacotherapy, glucose monitoring, medical nutrition therapy (MNT), and exercise.

Vista previa del contenido

NRSG 330 ENDOCRINE CASE STUDY



You work in the diabetes mellitus (DM) center at a large teaching hospital. The first patient you
meet is K.W., a 25-year-old Hispanic woman, who was just released from the hospital 2 days ago
after being diagnosed with type I DM.

Nine days ago, K.W. went to see the physician after a 1-month history of frequent urination,
thirst, severe fatigue, blurred vision, and some burning and tingling in her feet. She attributed
those symptoms to working long hours at the computer. Her random glucose level was 410
mg/dL. The next day her laboratory values were as follows: fasting glucose 335 mg/dL,
hemoglobin A1C (HbA1c) 8.8%, cholesterol 310 mg/dL, triglycerides 300 mg/dL, high-density
lipoprotein (HDL) 25 mg/dL, low-density lipoprotein (LDL) 160 mg/dL, ratio 12.4, and creatinine
0.9 mg/dL. Her body mass index is 37.6. Her blood pressure (BP) is 160/96 mm Hg. She was
admitted to the hospital for control of her glucose levels and the initiation of insulin therapy
with carbohydrate (CHO) counting. After discharge, K.W. has been referred to you for
comprehensive education. You are to cover four basic areas: pharmacotherapy, glucose
monitoring, medical nutrition therapy (MNT), and exercise.

1. K.W. was started on sliding scale lispro (Humalog) four times daily and glargine (Lantus)
insulin 30 units at bedtime. What is the most significant difference between these two insulin
therapies?

The difference is their onset, peak, and duration. Lispro is a fast-acting insulin analogue
with an onset of action within 15 minutes, a peak effect of ½ to 1 hour, and a duration of 3
to 4 hours. Patients using lispro are cautioned not to take it until they sit down to eat or
no sooner than 10 minutes before eating. Food intake must match insulin administered to
avoid hypoglycemia. The short duration necessitates frequent administration. Glargine
(Lantus) is basal insulin with no peak effect and a longer than 24-hour duration of action.
The risk of hypoglycemia is minimal. Its long duration allows for once daily injection.

2. K.W. says she knows people who “only take 2 shots” because they are on NPH and regular
insulin and wants to know why she can't do that. Explain the advantages of using the glargine
(Lantus) and lispro (Humalog) insulin regimen.

The most effective insulin regimen, with the best glycemic control, is the one that most
closely mimics normal insulin production by the body—the basal-bolus regimen, using
lispro, a bolus insulin, before meals and a long-acting basal background insulin once or
twice a day. Other advantages to this regimen are less weight gain and less nocturnal
hypoglycemia because glargine insulin provides steady-state coverage.


3. What specific points would you include regarding managing insulin therapy? Select all
that apply.
a. Store unused insulin in the freezer.

Información del documento

Subido en
21 de mayo de 2022
Número de páginas
4
Escrito en
2021/2022
Tipo
Examen
Contiene
Preguntas y respuestas
$9.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Smartsolutions
3.9
(520)
Vendido
2972
Seguidores
2545
Artículos
1165
Última venta
2 días hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes